Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

glaxosmithkline pharma a/s - bordetella pertussis, pertactin (prn/69 kilodalton ydermembranprotein), bordetella pertussis, toxoid, clostridium tetani, toxoid, corynebacterium diphtheria, toxoid, haemagglutinin, filamentØst, poliovirus type 1, stamme mahoney (inaktiveret), poliovirus type 2, stamme mef-1 (inaktiveret), poliovirus type 3, stamme saukett (inaktiveret) - injektionsvæske, suspension, hætteglas

Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

glaxosmithkline pharma a/s - bordetella pertussis, stamme tahoma phase 1, filamentøs hæmagglutinin (fha), bordetella pertussis, stamme tahoma phase 1, pertactin (prn/69 kilodalton ydermembranprotein), bordetella pertussis, stamme tahoma phase 1, toxoid, clostridium tetani, stamme massachusetts f1, toxoid, corynebacterium diphtheriae, stamme park williams nr. 8, toxoid, haemophilus influenza type b polysaccharid, poliovirus type 1, stamme mahoney (inaktiveret), poliovirus type 2, stamme mef-1 (inaktiveret), poliovirus type 3, stamme saukett (inaktiveret) - pulver og solvens til injektionsvæske, suspension

Den Europæiske Union - dansk - EMA (European Medicines Agency)

esteve pharmaceuticals gmbh - thiotepa - hematopoietic stem cell transplantation; neoplasms - antineoplastiske midler - thiotepa riemser is indicated, in combination with other chemotherapy medicinal products:with or without total body irradiation (tbi), as conditioning treatment prior to allogeneic or autologous haematopoietic progenitor cell transplantation (hpct) in haematological diseases in adult and paediatric patients;when high dose chemotherapy with hpct support is appropriate for the treatment of solid tumours in adult and paediatric patients. thiotepa riemser is indicated, in combination with other chemotherapy medicinal products:with or without total body irradiation (tbi), as conditioning treatment prior to allogeneic or autologous haematopoietic progenitor cell transplantation (hpct) in haematological diseases in adult and paediatric patients;when high dose chemotherapy with hpct support is appropriate for the treatment of solid tumours in adult and paediatric patients.

Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

novartis healthcare a/s - baclofen - injektions-/infusionsvæske, opløsning - 0,5 mg/ml

Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

orifarm a/s - baclofen - injektions-/infusionsvæske, opløsning - 0,5 mg/ml

Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

novartis healthcare a/s - baclofen - injektions-/infusionsvæske, opløsning - 2 mg/ml

Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

orifarm a/s - baclofen - injektions-/infusionsvæske, opløsning - 2 mg/ml

Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

novartis healthcare a/s - baclofen - injektions-/infusionsvæske, opløsning - 50 mikrogram/ml

Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

novartis healthcare a/s - baclofen - oral opløsning - 1 mg/ml

Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

novartis healthcare a/s - baclofen - tabletter - 10 mg